192 related articles for article (PubMed ID: 7856502)
1. FDA 'remains committed' to quick approval of AIDS drugs.
Am Pharm; 1994 Dec; NS34(12):14. PubMed ID: 7856502
[No Abstract] [Full Text] [Related]
2. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
[TBL] [Abstract][Full Text] [Related]
3. FDA evaluates accelerated approval process. Food and Drug Administration.
Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
[TBL] [Abstract][Full Text] [Related]
4. FDA clearance for ritonavir in children with AIDS.
AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
[No Abstract] [Full Text] [Related]
5. FDA approves AIDS drug.
Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
[No Abstract] [Full Text] [Related]
6. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
[TBL] [Abstract][Full Text] [Related]
7. Editorial: time to end the death trials.
James JS
AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
[TBL] [Abstract][Full Text] [Related]
8. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
Lovell MC
Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
[No Abstract] [Full Text] [Related]
9. FDA Advisory Committee stalemates on delavirdine.
AIDS Patient Care STDS; 1997 Apr; 11(2):96-7. PubMed ID: 11361773
[No Abstract] [Full Text] [Related]
10. AIDS task force grapples with faster access to protease drugs.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):6-11. PubMed ID: 11362314
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial that led to FDA approval of zidovudine is published.
Clin Pharm; 1987 Oct; 6(10):752. PubMed ID: 3333341
[No Abstract] [Full Text] [Related]
12. Europeans outraged over expanded access.
Alcorn K; Nary G; Pernet AG; Surchio JL; Weiner JD
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):48-51. PubMed ID: 11363519
[TBL] [Abstract][Full Text] [Related]
13. FDA approves two combo brand-name AIDS drugs.
Med Health; 2004 Aug; 58(31):3-4. PubMed ID: 15368717
[No Abstract] [Full Text] [Related]
14. AIDS activists seek speedy access to protease drugs...
Gavaghan H
Nature; 1995 Mar; 374(6517):4. PubMed ID: 7870168
[No Abstract] [Full Text] [Related]
15. Europe learns from US drug mistakes.
Alcorn K
J Int Assoc Physicians AIDS Care; 1996 Mar; 2(3):39. PubMed ID: 11363346
[TBL] [Abstract][Full Text] [Related]
16. AIDS drugs in development. Facts and comparisons.
Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
[No Abstract] [Full Text] [Related]
17. DOXIL approved by FDA.
AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
[No Abstract] [Full Text] [Related]
18. Abbott AIDS medicine gets FDA approval earlier than expected.
AIDS Read; 2000 Oct; 10(10):574. PubMed ID: 11068792
[No Abstract] [Full Text] [Related]
19. Protease inhibitor approvals: will people be cut off drug? Followup studies proposal needs support.
James JS
AIDS Treat News; 1996 Mar; (no 242):3. PubMed ID: 11363191
[TBL] [Abstract][Full Text] [Related]
20. Committee recommends approval of AIDS drug.
Minn Med; 1994 Jul; 77(7):55. PubMed ID: 8052209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
